| For: | Mohyeldin M, Shrivastava S, Allu SVV. Ibrutinib and atrial fibrillation: An in-depth review of clinical implications and management strategies. World J Cardiol 2024; 16(5): 269-273 [PMID: 38817647 DOI: 10.4330/wjc.v16.i5.269] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v16/i5/269.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Ibraheem Othman, Seyedeh Zahra (Mona) Moossavi, Samaneh Bayati, Yi Sin Chang, Shubrandu Sanjoy, Karolina Grzyb, Eric Sy, Kayla Cropper, Sandy Kassir, Waleed Sabry. Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia: Adverse Event Incidence, Management, and Outcomes in a Canadian Real-World Setting. Current Oncology 2025; 32(6) doi: 10.3390/curroncol32060296
|
| 3 |
Drew A. Wells, Zachery Halford, Kori Holman, Dennis Marjoncu. Cancer Therapy‐Induced Cardiotoxicity: A Narrative Review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2026; 46(2) doi: 10.1002/phar.70110
|
| 4 |
Rochelle Y. Benoit, Sheila Loshi, Craig S. Moore. Bruton's Tyrosine Kinase—Going Beyond the B Cell. Immunology 2026; 178(4) doi: 10.1111/imm.70126
|